US$ 22.57
is tirzepatide considered a glp-1 vs Semaglutide: What You Need to Know Comparing GLP-type therapies for weight
Description
[DOI] [PubMed] [Google Scholar] 44.Ahangarpour M., Kavianinia I., Harris P.W., Brimble M.A
Participants : Over 1,600 adults with obesity or overweight and type 2 diabetes

4 You'll begin to eat smaller portions and promote weight loss

In a cross-sectional study presented at the European Association for the Study of Diabetes annual meeting and published in Diabetes, Obesity and Metabolism , researchers surveyed adults with obesity who were using semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro, Eli Lilly) and asked about changes in their appetite, satiety and sensory perception after starting an incretin-based therapy

Its inevitable
Regulatory clarity (10 pts)